Products
Curaleaf Expands UK Formulary with 12 New Products
Curaleaf International has added 12 new cannabis-based products to its UK formulary, including the first UK-licensed CBN oil from its European grow facilities. The products are now available through participating UK clinics.
Curaleaf International, one of the largest cannabis companies operating in the UK medical market, has significantly expanded its product offering available to UK patients. The expansion includes new flower varieties, balanced oil formulations and a cannabinol (CBN) sleep product — the first such product from a major supplier to enter the UK licensed market.
